Semaglutide

Researchers use semaglutide to investigate GLP-1 receptor signaling, glucose homeostasis, hypothalamic appetite circuits, and cardiometabolic pathways. Published trials provide a benchmark evidence base that lab investigators reference in in vitro and in vivo work. All applications are laboratory-based, RUO only.

Semaglutide activates one receptor, GLP-1. Tirzepatide adds GIP as a second target, making it a dual agonist. Retatrutide targets three, adding the glucagon receptor. Labs stock semaglutide as the single-agonist control arm because that simpler profile makes it easier to isolate GLP-1 receptor contributions when comparing against dual or triple agonists.

A complete COA includes HPLC purity, mass spectrometry identity confirmation, physical appearance, and a lot number. On receipt, match the lot number on the document to the one on the vial. A mismatch means the COA does not cover the material you received.

It means 99% or more of the material, by HPLC analysis, is intact semaglutide rather than fragments or impurities. Purity does not establish sterility, biological activity, or suitability for any human use. Those conclusions require separate testing.

Follow the label and COA for this specific lot. Lyophilized peptides are generally stored cold and protected from light. Reconstituted material is generally refrigerated and used within a defined window. Specific conditions and timelines depend on your protocol and the lot’s own documentation.

No. This is a research chemical in the RUO category, legally distinct from FDA-approved drugs such as Ozempic and Wegovy. Researchers are responsible for confirming compliance with their own applicable regulations. This is not legal advice.

Available sizes are 5, 10, 20, and 30 mg. The right quantity depends entirely on the protocol's scale and the number of experimental runs planned. That determination belongs to the researcher, not the supplier.

The independent lab has no financial stake in the outcome. An in-house figure comes from the same organization selling the material, which creates a conflict of interest even when the testing is accurate. A third-party certificate gives the researcher an outside check on what they are buying.